Agios Pharma (AGIO) Posts Smaller Q1 Loss on Higher Revenues

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Agios Pharma (AGIO) Posts Smaller Q1 Loss on Higher Revenues

Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations and COVID-19 Response

April 30, 2020 7:00 AM EDT

First Quarter TIBSOVO® Net Revenue of $22.7 Million; Company Reiterates 2020 TIBSOVO® Net U.S. Revenue Guidance of $105115 Million

New Clinical Data from Mitapivat in Thalassemia Accepted for Presentation at the European Hematology Association Annual Congress in June

Proof-of-Concept Decision for Mitapivat in Sickle Cell Disease on Track for Mid-2020; Data to be Submitted for Presentation at the American Society of Hematology Annual Meeting

 Cash Conservation Efforts Extend Runway to the End of June 2022   

CAMBRIDGE, Mass.,... More